Alpha Tau Medical (DRTS) Non-Current Deferred Tax Liability (2025 - 2026)

Alpha Tau Medical's (DRTS) quarterly Non-Current Deferred Tax Liability came in at $85000.0 in Q1 2026, down 12.37% quarter-over-quarter from $97000.0 in Q4 2025.

Alpha Tau Medical (DRTS) Non-Current Deferred Tax Liability (2025 - 2026) Analysis & Trends

Alpha Tau Medical has disclosed Non-Current Deferred Tax Liability across 2 years of filings, most recently posting $85000.0 for Q1 2026.

  • Non-Current Deferred Tax Liability for Q1 2026 came in at $85000.0, changed N/A year-over-year; the trailing twelve-month figure through Mar 2026 was $85000.0 (changed N/A YoY), and the FY2025 annual result was $97000.0, changed N/A from the prior year.
  • Non-Current Deferred Tax Liability came in at $85000.0 for Q1 2026 at Alpha Tau Medical, down from $97000.0 in the prior quarter.
  • In the past five years, Non-Current Deferred Tax Liability ranged from a high of $160000.0 in Q2 2025 to a low of $85000.0 in Q1 2026.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Alterity Therapeutics 719,706.53 Bn 719,706.50 Bn -
2 Belite Bio 55,800.00 Bn 55,800.00 Bn -
3 Quantum Biopharma 18,182.30 Bn 18,182.29 Bn -
4 Legend Biotech 3,154.00 Bn 3,153.71 Bn 242.10 Mn
5 Akari Therapeutics 1,844.30 Bn 1,844.29 Bn -
6 Evaxion A 1,567.96 Bn 1,567.94 Bn -
7 Psyence Biomedical 251.43 Bn 251.42 Bn -
8 Vertex Pharmaceuticals 112.56 Bn 105.31 Bn 2.59 Bn
9 Abivax 94.37 Bn 94.37 Bn -
10 Alpha Tau Medical 2,416.70 -76.42 Mn -

Historic Data

Download Data
DateValue
Mar 31, 2026 85,000.00
Mar 31, 2026 85,000.00
Dec 31, 2025 97,000.00
Dec 31, 2025 97,000.00
Sep 30, 2025 151,000.00
Sep 30, 2025 151,000.00
Jun 30, 2025 160,000.00
Jun 30, 2025 160,000.00